None
Quote | Armata Pharmaceuticals Inc. (NYSE:ARMP)
Last: | $2.53 |
---|---|
Change Percent: | 0.4% |
Open: | $2.5 |
Close: | $2.53 |
High: | $2.61 |
Low: | $2.37 |
Volume: | 16,769 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Armata Pharmaceuticals Inc. (NYSE:ARMP)
2024-03-21 17:19:19 ET More on Armata Pharmaceuticals Armata enters $35M credit agreement with Innoviva Seeking Alpha’s Quant Rating on Armata Pharmaceuticals Historical earnings data for Armata Pharmaceuticals Financial information for Armata Pharmace...
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , March 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology com...
Message Board Posts | Armata Pharmaceuticals Inc. (NYSE:ARMP)
Subject | By | Source | When |
---|---|---|---|
Interesting article. | gumshoe22 | investorshub | 07/08/2022 4:18:38 PM |
Here's an interesting article on how a bacteriophage | lesgetrich | investorshub | 01/15/2022 4:20:37 PM |
ARMATA MORE GOOD NEWS FDA Clearance | gator16 | investorshub | 11/18/2021 2:28:35 PM |
There was a PR last Friday... | lesgetrich | investorshub | 11/03/2021 3:50:03 PM |
Do I detect a pulse? | gumshoe22 | investorshub | 11/03/2021 3:31:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Armata Pharmaceuticals Inc. Company Name:
ARMP Stock Symbol:
NYSE Market:
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , March 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology com...
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva PR Newswire Proceeds to be used to continue to advance rigorously designed clinical trials of Armata's high purity phage-based therapeutic candidates LOS ANGELES , March 4, 20...
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit PR Newswire LOS ANGELES , Feb. 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on...